P2RX1 and acute lymphoblastic leukemia: Through RNA sequencing assays combined with functional assays assessing proliferation, apoptosis, mitochondrial function, and metabolism, we identified key downstream molecular pathways influenced by P2RX1, revealing its potential as a therapeutic target in Ph+ ALL.